Scientists Identify New Mechanism of Insulin Resistance

Normal blood glucose (sugar) control depends on insulin, a hormone that's released after eating that stimulates sugar uptake in muscles and other parts of the body. Insulin resistance arises when the body no longer responds to insulin's signals. It's a serious condition that often accompanies obesity and increases risk of developing type 2 diabetes, a disease marked by dangerously high blood sugar levels. Scientists have been studying the disorder for years, but have not been able to agree upon its root cause.

But Debbie Muoio, an assistant professor of medicine in Duke's Sarah W. Stedman Nutrition and Metabolism Center thinks she may have a pretty good idea. She and her colleagues trace the development of insulin resistance to overworked mitochondria – the tiny power plants inside each cell – that simply get worn down and worn out trying to burn excess fat.

The study appears in the current issue of Cell Metabolism.

Normally, the body switches fuel sources during the day, says Muoio, a phenomenon known as "metabolic flexibility."

"For example, overnight and during periods of fasting or exercise, muscles and other organs in the body burn fat as fuel. That's because there is usually more fat available at that time. But during the day, and especially after a meal, mitochondria switch to glucose," she says. This makes sense, because food makes more glucose available and healthy individuals increase glucose use when it's on hand. But there's the hitch: If the diet is consistently too rich in fat and calories, the switchover does not occur. The mitochondria just keep working harder and harder to burn all the fat, and the effort eventually fails.

This is what leads to a "metabolic traffic jam," – a mitochondrial gridlock where fat accumulates and blocks the use, or metabolism, of glucose. Muoio believes that chronically stressed mitochondria send out a distress signal that prevents insulin from doing its job, allowing sugar to build up in the blood.

"We think this is what leads to insulin resistance," says Muoio, who acknowledges that the idea is not entirely new. "The first seeds of this hypothesis were actually planted fifty years ago, but it died out because researchers lacked the investigative tools to prove it."

Now, they have them. Muoio's team used a mass spectrometer to identify mitochondrial metabolites – by-products of fat-burning – that were found to be associated with obesity and the onset of insulin resistance.

They also developed cell and animal models that showed that when deprived of a fat-importing enzyme, mitochondria were protected and muscles continued to respond to insulin's signals, suggesting that fat overload was indeed the culprit.

There is some good news in all of this, though, says Muoio. "There are two very easy ways to prevent insulin resistance: Exercise more – you'll help mitochondria burn fat more effectively, or eat less fat in your diet. That's always easier said than done, of course."

Several other investigators from the Stedman Center contributed to the research, including lead author Timothy Koves, Robert Noland, Dorothy Slentz, Merrie Mosedale, Olga Ilkayeva, James Bain, Robert Stevens and Christopher Newgard. Additional co-authors include Gary Lopaschuk, John Ussher and Jason Dyck, from the University of Alberta. Lopaschuk and Dyck investment in a company interested in developing inhibitors to an enzyme central to the mitochondrial activity described in the study.

Source: Duke University Medical Center

Protein deficiency leads to faster fat burning in mice, study shows
Researchers have developed a new, lean mouse with characteristics suggesting that someday, using medication to manipulate a specific protein in humans could emerge as a strategy to treat obesity and disorders associated with excess weight, such as diabetes and metabolic syndrome.
Obesity chokes up the cellular power plant
The machinery responsible for energy production in fat cells is working poorly as a result of obesity. Finnish research done at the University of Helsinki and the National Public Health Institute shows that this may aggravate and work to maintain the obese state in humans.
Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
Sirtris Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced today that findings in the journal Nature demonstrate that Sirtris has developed novel drug candidates that offer a promising, new approach to treating diseases of aging, including Type 2 Diabetes, by targeting SIRT1, a gene that controls the aging process.
Body-weight regulation scientists give perspective on obesity-related research
When obesity overloads the body with excess nutrients, parts start to fail. Obesity contributes to heart disease, stroke, diabetes, high blood pressure, some cancers, liver disease, immune dysfunction, painful joints, and a host of other problems. With so many parts of the body affected, studies of the health effects of obesity that concentrate on one body organ or system may overlook common underlying events occurring at the cellular level throughout the body.
Power-boosting signal in muscle declines with age
As people age, they may have to exercise even harder to get the benefits afforded to younger folk. That's the suggestion of a report in the February issue of the journal Cell Metabolism, published by Cell Press, showing that a signal that gives muscles a kind of metabolic boost in response to exercise is blunted in older animals.
Single Molecule Makes Obese Mice Healthy
Researchers have used a single compound to increase the lifespan of obese mice, and found that the drug reversed nearly all of the changes in gene expression patterns found in mice on high calorie diets—some of which are associated with diabetes, heart disease, and other significant diseases related to obesity. The research, led by investigators at Harvard Medical School and the National Institute on Aging, is the first time that the small molecule resveratrol has been shown to offer survival benefits in a mammal. The study is reported in the November 1 advanced online edition of Nature.
Killing 'angry' immune cells in fat could fight diabetes
By killing off "angry" immune cells that take up residence in obese fat and muscle tissue, researchers have shown that they can rapidly reverse insulin resistance in obese mice. The findings reported in the October Cell Metabolism, a publication of Cell Press, suggest that treatments aimed at specific subsets of the so-called macrophage cells might offer a very effective new antidiabetic therapy, according to the researchers.
Metabolic syndrome ups colorectal cancer risk
In a large U.S. population-based study presented at the 73rd Annual Scientific Meeting of the American College of Gastroenterology, metabolic syndrome patients had a 75 percent higher risk of colorectal cancer compared to those without metabolic syndrome.

Scientists Identify New Mechanism of Insulin Resistance

Related stories:

News discussion: